SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Stridh Pernilla)
 

Search: WFRF:(Stridh Pernilla) > Umeå University > Uppsala University > Molecular mimicry b...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk

Tengvall, Katarina, 1980- (author)
Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
Huang, Jesse (author)
Karolinska Inst, Karolinska Neuroimmunol & Multiple Sclerosis Ctr, Dept Clin Neurosci, Neuroimmunol Unit, S-17176 Stockholm, Sweden.;Karolinska Univ Hosp, Ctr Mol Med, S-17176 Stockholm, Sweden.
Hellström, Cecilia (author)
KTH,Proteinvetenskap,Science for Life Laboratory, SciLifeLab
show more...
Kammer, Patrick (author)
German Canc Res Ctr, Infect & Canc Epidemiol Infect Inflammat & Canc R, D-69120 Heidelberg, Germany.
Biström, Martin (author)
Umeå universitet,Klinisk neurovetenskap,Umea Univ, Dept Pharmacol & Clin Neurosci, S-90185 Umea, Sweden.
Ayoglu, Burcu (author)
KTH,Science for Life Laboratory, SciLifeLab,Proteinvetenskap
Bomfim, Izaura Lima (author)
Karolinska Inst, Karolinska Neuroimmunol & Multiple Sclerosis Ctr, Dept Clin Neurosci, Neuroimmunol Unit, S-17176 Stockholm, Sweden.;Karolinska Univ Hosp, Ctr Mol Med, S-17176 Stockholm, Sweden.
Stridh, Pernilla (author)
Karolinska Institutet
Butt, Julia (author)
German Canc Res Ctr, Infect & Canc Epidemiol Infect Inflammat & Canc R, D-69120 Heidelberg, Germany.
Brenner, Nicole (author)
German Canc Res Ctr, Infect & Canc Epidemiol Infect Inflammat & Canc R, D-69120 Heidelberg, Germany.
Michel, Angelika (author)
German Canc Res Ctr, Infect & Canc Epidemiol Infect Inflammat & Canc R, D-69120 Heidelberg, Germany.
Lundberg, Karin (author)
Karolinska Institutet
Padyukov, Leonid (author)
Karolinska Institutet
Lundberg, Ingrid E. (author)
Karolinska Institutet
Svenungsson, Elisabet (author)
Karolinska Institutet
Ernberg, Ingemar (author)
Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.
Olafsson, Sigurgeir (author)
Amgen Inc, deCODE Genet, IS-101 Reykjavik, Iceland.
Dilthey, Alexander T. (author)
Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.;Heinrich Heine Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany.
Hillert, Jan (author)
Karolinska Institutet
Alfredsson, Lars (author)
Karolinska Institutet
Sundström, Peter (author)
Umeå universitet,Klinisk neurovetenskap,Umea Univ, Dept Pharmacol & Clin Neurosci, S-90185 Umea, Sweden.
Nilsson, Peter (author)
KTH,Science for Life Laboratory, SciLifeLab,Proteinvetenskap
Waterboer, Tim (author)
German Canc Res Ctr, Infect & Canc Epidemiol Infect Inflammat & Canc R, D-69120 Heidelberg, Germany.
Olsson, Tomas (author)
Karolinska Institutet
Kockum, Ingrid (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2019-08-02
2019
English.
In: Proceedings of the National Academy of Sciences of the United States of America. - : NATL ACAD SCIENCES. - 0027-8424 .- 1091-6490. ; 116:34, s. 16955-16960
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Multiple sclerosis (MS) is a chronic inflammatory, likely autoimmune disease of the central nervous system with a combination of genetic and environmental risk factors, among which Epstein-Barr virus (EBV) infection is a strong suspect. We have previously identified increased autoantibody levels toward the chloride-channel protein Anoctamin 2 (ANO2) in MS. Here, IgG antibody reactivity toward ANO2 and EBV nuclear antigen 1 (EBNA1) was measured using bead-based multiplex serology in plasma samples from 8,746 MS cases and 7,228 controls. We detected increased anti-ANO2 antibody levels in MS (P = 3.5 x 10(-36)) with 14.6% of cases and 7.8% of controls being ANO2 seropositive (odds ratio [OR] = 1.6; 95% confidence intervals [95% CI]: 1.5 to 1.8). The MS risk increase in ANO2-seropositive individuals was dramatic when also exposed to 3 known risk factors for MS: HLA-DRB1*15: 01 carriage, absence of HLA-A*02: 01, and high anti-EBNA1 antibody levels (OR = 24.9; 95% CI: 17.9 to 34.8). Reciprocal blocking experiments with ANO2 and EBNA1 peptides demonstrated antibody cross-reactivity, mapping to ANO2 [aa 140 to 149] and EBNA1 [aa 431 to 440]. HLA gene region was associated with anti-ANO2 antibody levels and HLADRB1*04: 01 haplotype was negatively associated with ANO2 seropositivity (OR = 0.6; 95% CI: 0.5 to 0.7). Anti-ANO2 antibody levels were not increased in patients from 3 other inflammatory disease cohorts. The HLA influence and the fact that specific IgG production usually needs T cell help provides indirect evidence for a T cell ANO2 autoreactivity in MS. We propose a hypothesis where immune reactivity toward EBNA1 through molecular mimicry with ANO2 contributes to the etiopathogenesis of MS.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Keyword

Anoctamin 2
ANO2
multiple sclerosis
molecular mimicry
Epstein-Barr virus

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view